在药剂师参与门诊儿科喘诊所后,喘控制的改善
Lauren Anthony1, Sandra Axtell1, Bianca Nixon1
1Cleveland Clinic Hillcrest Hospital, Mayfield Heights, OH, USA.
Journal of pharmacy practice
|February 15, 2025
概括
门诊药剂师访问显著改善了儿科喘控制,100%的患者实现了控制. 这些干预措施还减少了急诊和类固醇疗程,突出了药剂师护理在儿童喘管理中的价值.
科学领域:
- 儿科肺病学 儿科肺病学
- 临床药房 临床药房
- 公共卫生 公共卫生
背景情况:
- 喘是一种普遍的儿科疾病,但对控制喘的门诊药房干预措施的数据有限.
- 有效的管理策略对于改善儿童的生活质量和减少医疗保健负担至关重要.
研究的目的:
- 评估门诊药剂师访问对儿科喘控制的影响.
- 用喘控制测试 (ACT) 和儿童喘控制测试 (C-ACT) 来评估喘控制的变化.
主要方法:
- 一项涉及16名患有喘的儿科患者 (6-17岁) 的研究显示,在12周内,他们接受了2-3次门诊药剂师访问.
- 测量结果包括ACT/C-ACT得分的变化,吸入器技术,药物坚持和新出现的干预措施.
主要成果:
- 在喘控制得分中观察到3个点的统计学上显著的中位数改善 (P=0.0348).
- 喘控制从基线时的50%提高到干预后的100% (P=0.0053).
- 与喘相关的突发干预 (类固醇疗程,ED访问,住院治疗) 在干预后显著下降 (P=0.0464).
结论:
- 门诊药剂师干预表明对儿科喘控制有可衡量的积极影响.
- 药剂师主导的护理可以提高吸入器技术,改善吸入力,并减少儿童急性喘恶化.
相关概念视频
Asthma-IV: Nursing Management
2.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
2.9K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
231
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
231
COPD: Management Using Bronchodilators and Corticosteroids
173
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
173
Inhaled Medications
219
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
219
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K


